📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Increased systemic and adipose 11ß-HSD1 activity in idiopathic intracranial hypertension. (2022)

First Author: Westgate CSJ

Attributed to: MICA: Assessing the therapeutic efficacy of 11beta-hydroxysteroid dehydrogenase type 1 inhibitor (AZD4017) in idiopathic intracranial hypertension funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1530/eje-22-0108

PubMed Identifier: 35584002

Publication URI: http://europepmc.org/abstract/MED/35584002

Type: Journal Article/Review

Volume: 187

Parent Publication: European journal of endocrinology

Issue: 2

ISSN: 0804-4643